147 related articles for article (PubMed ID: 38047214)
1. Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial.
Lorton O; Achard V; Koutsouvelis N; Jaccard M; Vanhoutte F; Dipasquale G; Ost P; Zilli T
Adv Radiat Oncol; 2023; 8(6):101290. PubMed ID: 38047214
[TBL] [Abstract][Full Text] [Related]
2. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Achard V; Jaccard M; Vanhoutte F; Siva S; Heikkilä R; Dirix P; Liefhooghe N; Otte FX; Gomez-Iturriaga A; Berghen C; Shelan M; Conde-Moreno A; López Campos F; Papachristofilou A; Guckenberger M; Meersschout S; Putora PM; Zwahlen D; Couñago F; Scorsetti M; Eito C; Barrado M; Zapatero A; Muto P; Van De Voorde L; Lamanna G; Koutsouvelis N; Dipasquale G; Ost P; Zilli T
Radiother Oncol; 2022 Jul; 172():1-9. PubMed ID: 35476942
[TBL] [Abstract][Full Text] [Related]
3. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer.
Hall WA; Paulson E; Davis BJ; Spratt DE; Morgan TM; Dearnaley D; Tree AC; Efstathiou JA; Harisinghani M; Jani AB; Buyyounouski MK; Pisansky TM; Tran PT; Karnes RJ; Chen RC; Cury FL; Michalski JM; Rosenthal SA; Koontz BF; Wong AC; Nguyen PL; Hope TA; Feng F; Sandler HM; Lawton CAF
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):174-185. PubMed ID: 32861817
[TBL] [Abstract][Full Text] [Related]
4. Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
De Hertogh O; Le Bihan G; Zilli T; Palumbo S; Jolicoeur M; Crehange G; Derashodian T; Roubaud G; Salembier C; Supiot S; Chapet O; Achard V; Sargos P
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):29-40. PubMed ID: 37506982
[TBL] [Abstract][Full Text] [Related]
5. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
Lawton CA; Michalski J; El-Naqa I; Buyyounouski MK; Lee WR; Menard C; O'Meara E; Rosenthal SA; Ritter M; Seider M
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):383-7. PubMed ID: 18947938
[TBL] [Abstract][Full Text] [Related]
6. ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer.
Dal Pra A; Dirix P; Khoo V; Carrie C; Cozzarini C; Fonteyne V; Ghadjar P; Gomez-Iturriaga A; Panebianco V; Zapatero A; Bossi A; Wiegel T
Clin Transl Radiat Oncol; 2023 Jul; 41():100638. PubMed ID: 37251620
[TBL] [Abstract][Full Text] [Related]
7. PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.
De Bruycker A; Spiessens A; Dirix P; Koutsouvelis N; Semac I; Liefhooghe N; Gomez-Iturriaga A; Everaerts W; Otte F; Papachristofilou A; Scorsetti M; Shelan M; Siva S; Ameye F; Guckenberger M; Heikkilä R; Putora PM; Zapatero A; Conde-Moreno A; Couñago F; Vanhoutte F; Goetghebeur E; Reynders D; Zilli T; Ost P
BMC Cancer; 2020 May; 20(1):406. PubMed ID: 32398040
[TBL] [Abstract][Full Text] [Related]
8. OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.
Supiot S; Vaugier L; Pasquier D; Buthaud X; Magné N; Peiffert D; Sargos P; Crehange G; Pommier P; Loos G; Hasbini A; Latorzeff I; Silva M; Denis F; Lagrange JL; Morvan C; Campion L; Blanc-Lapierre A
Eur Urol; 2021 Oct; 80(4):405-414. PubMed ID: 34247896
[TBL] [Abstract][Full Text] [Related]
9. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update.
Small W; Bosch WR; Harkenrider MM; Strauss JB; Abu-Rustum N; Albuquerque KV; Beriwal S; Creutzberg CL; Eifel PJ; Erickson BA; Fyles AW; Hentz CL; Jhingran A; Klopp AH; Kunos CA; Mell LK; Portelance L; Powell ME; Viswanathan AN; Yacoub JH; Yashar CM; Winter KA; Gaffney DK
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):413-424. PubMed ID: 32905846
[TBL] [Abstract][Full Text] [Related]
10. Dedicated MRI simulation for cervical cancer radiation treatment planning: Assessing the impact on clinical target volume delineation.
Veera J; Lim K; Dowling JA; O'Connor C; Holloway LC; Vinod SK
J Med Imaging Radiat Oncol; 2019 Apr; 63(2):236-243. PubMed ID: 30506944
[TBL] [Abstract][Full Text] [Related]
11. Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.
Franco P; Arcadipane F; Trino E; Gallio E; Martini S; Iorio GC; Piva C; Moretto F; Ruo Redda MG; Verna R; Tseroni V; Bona C; Pozzi G; Fiandra C; Ragona R; Bertetto O; Ricardi U
Clin Transl Radiat Oncol; 2018 Jun; 11():33-39. PubMed ID: 29928706
[TBL] [Abstract][Full Text] [Related]
12. Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.
Trignani M; Argenone A; Di Biase S; Musio D; Merlotti A; Ursino S; Orlandi E; Genovesi D; Bacigalupo A
Radiol Med; 2019 Jul; 124(7):682-692. PubMed ID: 30852793
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer : An investigation of 117 pelvic lymph nodes.
Cozzi S; Botti A; Timon G; Blandino G; Najafi M; Manicone M; Bardoscia L; Ruggieri MP; Ciammella P; Iotti C
Strahlenther Onkol; 2022 Aug; 198(8):700-709. PubMed ID: 34757443
[TBL] [Abstract][Full Text] [Related]
14. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates.
De Bruycker A; De Bleser E; Decaestecker K; Fonteyne V; Lumen N; De Visschere P; De Man K; Delrue L; Lambert B; Ost P
Eur Urol; 2019 May; 75(5):826-833. PubMed ID: 30503072
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography.
Saripalli AL; Lee B; Adams W; Bhandare N; Venkatesulu BP; Yoo RK; Price J; Harmon GA; Block AM; Friedman N; Harkenrider MM; Major EJ; Small W; Wagner RH; Welsh JS; Solanki AA
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):630-640. PubMed ID: 37201758
[TBL] [Abstract][Full Text] [Related]
16. Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer.
Liskamp CP; Donswijk ML; van der Poel HG; Schaake EE; Vogel WV
Clin Transl Radiat Oncol; 2020 May; 22():9-14. PubMed ID: 32154392
[TBL] [Abstract][Full Text] [Related]
17. Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial.
Song YC; Yan XN; Tang Y; Jing H; Zhang N; Zhang J; Zhong YH; Dong LH; Wu HF; Tie J; Zhong QZ; Yang WF; Wang XH; Hou XR; Lu YF; Zhao LN; Jin J; Li YX; Wang SL
Pract Radiat Oncol; 2022; 12(5):397-408. PubMed ID: 36058618
[TBL] [Abstract][Full Text] [Related]
18. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
[TBL] [Abstract][Full Text] [Related]
19. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.
Meijer HJ; van Lin EN; Debats OA; Witjes JA; Span PN; Kaanders JH; Barentsz JO
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1405-10. PubMed ID: 21640507
[TBL] [Abstract][Full Text] [Related]
20. PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
Schiller K; Stöhrer L; Düsberg M; Borm K; Devecka M; Vogel MME; Tauber R; Heck MM; Rauscher I; Eiber M; Gschwend JE; Duma MN; Combs SE
Eur Urol Oncol; 2021 Feb; 4(1):73-83. PubMed ID: 32451312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
